However, a retrospective study of elderly NSCLC patients treated with PD-1 inhibitors (35) reported no significant correlation between baseline LIPI classification and irAEs risk, though changes in LIPI scores during treatment significantly predicted irAEs occurrence. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.